BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 10483998)

  • 1. Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori.
    Hirasawa R; Tatsuta M; Iishi H; Yano H; Baba M; Uedo N; Sakai N
    Am J Gastroenterol; 1999 Sep; 94(9):2398-402. PubMed ID: 10483998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in ornithine decarboxylase activity after eradication of Helicobacter pylori.
    Alam K; Arlow FL; Ma CK; Schubert TT
    Am J Gastroenterol; 1994 Jun; 89(6):888-93. PubMed ID: 8198100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
    Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
    Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
    Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
    Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis.
    Konturek PC; Konturek SJ; Bobrzyński A; Kwiecień N; Obtułowicz W; Stachura J; Hahn EG; Rembiarz K
    J Physiol Pharmacol; 1997 Sep; 48(3):365-73. PubMed ID: 9376619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
    Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G
    Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
    Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG
    Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of eradication therapy in patients with chronic atrophic gastritis and seropositivity for anti-HP antibodies and histological negativity for Helicobacter pylori].
    Leri O; Mastropasqua M; Scopelliti G; Grasso E; Losi T; Iadicicco A; Perinelli P
    Clin Ter; 1999; 150(5):343-6. PubMed ID: 10687264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
    Joh T; Sasaki M; Kataoka H; Tanida S; Itoh K; Kondo Y; Ogasawara N; Oshima T; Okada N; Ohara H; Sano H; Nakao H; Sobue S; Itoh M
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1344-51. PubMed ID: 16105119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa.
    Tatsuguchi A; Miyake K; Gudis K; Futagami S; Tsukui T; Wada K; Kishida T; Fukuda Y; Sugisaki Y; Sakamoto C
    Am J Gastroenterol; 2004 Nov; 99(11):2121-7. PubMed ID: 15554990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the proliferating compartment of gastric mucosa during Helicobacter pylori infection: the putative role of epithelial cells expressing p27(kip1).
    Sougioultzis S; Foukas PG; Tzivras M; Kourtessas D; Gorgoulis VG; Davaris P; Archimandritis AJ
    Mod Pathol; 2003 Nov; 16(11):1076-85. PubMed ID: 14614046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection.
    McCarthy CJ; Crofford LJ; Greenson J; Scheiman JM
    Am J Gastroenterol; 1999 May; 94(5):1218-23. PubMed ID: 10235197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].
    Yang G; Hu F; Jia J
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
    Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
    Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric epithelial cell turnover and mucosal protection in Japanese children with Helicobacter pylori infection.
    Ozawa K; Kato S; Sekine H; Koike T; Minoura T; Iinuma K; Nagura H
    J Gastroenterol; 2005 Mar; 40(3):236-46. PubMed ID: 15830282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.